<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>NISCAIR Online Periodicals Repository Collection: IJC-B Vol.51B(11) [November 2012]</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14970</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/14991" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/14990" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/14989" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/14988" />
      </rdf:Seq>
    </items>
  </channel>
  <textInput>
    <title>The Collection's search engine</title>
    <description>Search the Channel</description>
    <name>search</name>
    <link>http://nopr.niscair.res.in/simple-search</link>
  </textInput>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/14991">
    <title>Design, synthesis, biological evaluation of thiazolyl schiff base derivatives as novel  anti-inflammatory agents</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14991</link>
    <description>Title: Design, synthesis, biological evaluation of thiazolyl schiff base derivatives as novel  anti-inflammatory agents
&lt;br/&gt;
&lt;br/&gt;Authors: Bhosale, P P; Chavan, R S; Bhosale, A V
&lt;br/&gt;
&lt;br/&gt;Abstract:   A series of new&#xD;
4-(4-substitutedphenyl)-N-(4-substituted­benzylidene)-thiazol-2-amine&#xD;
derivatives &lt;b style="mso-bidi-font-weight:normal"&gt;5a-l&lt;/b&gt; has been synthe­sized&#xD;
and evaluated for their anti-inflammatory and analgesic activities at a dose of&#xD;
50 mg/kg p.o. The most active compounds &lt;b&gt;5a, 5j&lt;/b&gt; have been subjected to&#xD;
acute ulcerogenesis study at a dose of 150 mg/kg. The structure of all these&#xD;
compounds have been established on the basis of spectral (IR, &lt;sup&gt;1&lt;/sup&gt;H NMR&#xD;
data) studies.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1649-1654</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/14990">
    <title>Synthesis, characterization and antimicrobial screening of some novel chalcones and their derivatives</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14990</link>
    <description>Title: Synthesis, characterization and antimicrobial screening of some novel chalcones and their derivatives
&lt;br/&gt;
&lt;br/&gt;Authors: Chate, Asha V; Joshi, Ratnadeep S; Mandhane, Priyanka G; Gill, Charansingh H
&lt;br/&gt;
&lt;br/&gt;Abstract:   Synthesis of some novel&#xD;
2-(4-(allyloxy)-3-methoxyphenyl)-4&lt;i style="mso-bidi-font-style:normal"&gt;H&lt;/i&gt;-chromen-4-ones&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;5a-f&lt;/b&gt; and&#xD;
2-(4-(allyloxy)-3-methoxyphenyl)-3-chloro-4&lt;i style="mso-bidi-font-style:normal"&gt;H&lt;/i&gt;-chromen-4-ones&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;6a-f&lt;/b&gt; by oxidative cyclisation of (&lt;i style="mso-bidi-font-style:normal"&gt;E&lt;/i&gt;)-3-(4-allyloxy)-3-methoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-ones&#xD;
using DMSO/I&lt;sub&gt;2&lt;/sub&gt; and DMSO/CuCl&lt;sub&gt;2&lt;/sub&gt; at reflux condition has been&#xD;
carried out. A useful and efficient synthetic strategy for the synthesis of&#xD;
4-allyloxy-3-methoxyphenyl chromones has been reported. The synthesized&#xD;
compounds have been characterized by melting point, FT-IR, NMR and EI-MS&#xD;
spectral data. The synthesized compounds have been evaluated for their&#xD;
antibacterial and antifungal activities. Most of the compounds are found to be&#xD;
of comparable potency when compared with the reference standard drugs.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1642-1648</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/14989">
    <title>Synthesis and antimicrobial activity studies of certain pyrimidinyl oxadiazolo azetidinones</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14989</link>
    <description>Title: Synthesis and antimicrobial activity studies of certain pyrimidinyl oxadiazolo azetidinones
&lt;br/&gt;
&lt;br/&gt;Authors: George, Sonia; Sabitha, R; Govindhammal, V; Ravi, T K
&lt;br/&gt;
&lt;br/&gt;Abstract:   Aryl substituted pyrimidinyl oxadiazolo&#xD;
azetidinones have been synthesized from ethyl&#xD;
6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate &lt;b style="mso-bidi-font-weight:normal"&gt;1 &lt;/b&gt;which on reaction with semicarbazide&#xD;
hydrochloride in ethanol yields&#xD;
2-[(6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)carbonyl]hydra­zi­ne­carboxamide&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;2&lt;/b&gt;.&lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt; &lt;/b&gt;Compound &lt;b style="mso-bidi-font-weight:normal"&gt;2&lt;/b&gt;, on reaction&#xD;
with concentrated sulphuric acid, undergo cyclization to yield&#xD;
5-(5-amino-1,3,4-oxadiazol-2-yl)-6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1&lt;i&gt;H&lt;/i&gt;)-one&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;3&lt;/b&gt;. Further, compound &lt;b style="mso-bidi-font-weight:normal"&gt;3&lt;/b&gt;, on treatment with appropriate&#xD;
aldehydes, in ethanol give 6-methyl-4-phenyl-5-(5-{[(1&lt;i&gt;E&lt;/i&gt;)-aryl­methyl­idene]amino}-1,3,4-oxadiazol-2-yl)-3,4-dihydropyrimidin-2(1&lt;i&gt;H&lt;/i&gt;)-ones&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;4a-e&lt;/b&gt;.&lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt; &lt;/b&gt;Finally, the title compounds&#xD;
5-[5-(3-chloro-2-oxo-4-arylazetidin-1-yl)-1,3,4-oxadiazol-2-yl]-6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1&lt;i&gt;H&lt;/i&gt;)-ones&lt;b style="mso-bidi-font-weight:normal"&gt;&#xD;
5a-e &lt;/b&gt;have been obtained by&#xD;
ring closure of the compounds &lt;b style="mso-bidi-font-weight:normal"&gt;4a-e &lt;/b&gt;with&#xD;
monochloroacetyl chloride in dioxane in the presence of triethylamine. The&#xD;
structures of the novel compounds are assigned based on IR, &lt;sup&gt;1&lt;/sup&gt;H NMR,&#xD;
mass spectral data and elemental analysis data. All the compounds have been&#xD;
screened for their antimicrobial activity using bacterial and fungal strains.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1637-1641</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/14988">
    <title>Development of HPLC method for simultaneous estimation of ambroxol, guaifenesin and salbutamol in  single dose form</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14988</link>
    <description>Title: Development of HPLC method for simultaneous estimation of ambroxol, guaifenesin and salbutamol in  single dose form
&lt;br/&gt;
&lt;br/&gt;Authors: Dubey, Nidhi; Sahu, Sandeep; Singh, G N
&lt;br/&gt;
&lt;br/&gt;Abstract:   A simple, accurate and&#xD;
precise High Performance Liquid Chromatographic (HPLC) method has been&#xD;
developed for simultaneous determination of ambroxol, guaifenesin and&#xD;
salbutamol in single dosage form. The method has been validated as per the&#xD;
guidelines of ICH and FDA. The finalized Reverse Phase–HPLC method is revealed&#xD;
with significant shorter retention time of 15 min with simple isocratic&#xD;
program. The separation is achieved on C- 8, 5μm; 250 mm × 4.6 mm column with&#xD;
flow rate 1.0 mL per minute in isocratic mode using disodium&#xD;
hydrogen-ortho-phosphate buffer (&lt;i&gt;p&lt;/i&gt;H 4.5) and methanol as mobile phase.&#xD;
Column oven temperature is maintained at 25&lt;span style="mso-bidi-font-weight:&#xD;
bold"&gt;°C and observations are recorded at 220 nm. The method is simple,&#xD;
accurate, reproducible and short and can be used for simultaneous analysis of&#xD;
ambroxol, guaifenesin and salbutamol in several single dose form formulation&#xD;
available in the market.&#xD;
&#xD;
&lt;/span&gt;
&lt;br/&gt;
&lt;br/&gt;Page(s): 1633-1636</description>
  </item>
</rdf:RDF>

